Skip to menu Skip to content Skip to footer

2005

Journal Article

Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system

Rizkalla, Bishoy, Forbes, Josephine M., Cao, Zemin, Boner, Geoffrey and Cooper, Mark E. (2005). Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. Journal of Hypertension, 23 (1), 153-164. doi: 10.1097/00004872-200501000-00026

Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system

2005

Journal Article

Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy

Thomas, M. C., Forbes, J. M. and Cooper, M. E. (2005). Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy. Annals of the New York Academy of Sciences, 1043 (1), 927-927. doi: 10.1196/annals.1333.141

Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy

2005

Conference Publication

Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?

Forbes, JM, Coughlan, MT, Fukami, K, Laskowski, A, Thallas-Bonke, V, Dinh, D, Long, DM, Brownlee, M, Cooper, ME and Thorburn, DR (2005). Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?

2005

Conference Publication

Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?

Thomas, Merlin C., Forbes, Josephine M., MacIsaac, Richard, Jerums, George and Cooper, Mark E. (2005). Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?. New York Academy of Sciences. doi: 10.1196/annals.1333.073

Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?

2004

Journal Article

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway

Thallas-Bonke, Vicki, Lindschau, Carsten, Rizkalla, Bishoy, Bach, Leon A., Boner, Geoffrey, Meier, Matthias, Haller, Hermann, Cooper, Mark E. and Forbes, Josephine M. (2004). Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway. Diabetes, 53 (11), 2921-2930. doi: 10.2337/diabetes.53.11.2921

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway

2004

Journal Article

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes

Forbes, Josephine M., Thomas, Merlin C., Thorpe, Suzanne R., Alderson, Nathan L. and Cooper, Mark E. (2004). The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes. Kidney International, Supplement, 66 (S92), S105-S107. doi: 10.1111/j.1523-1755.2004.09225.x

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes

2004

Journal Article

The role of advanced glycation in reduced organic cation transport associated with experimental diabetes

Thomas, Merlin C., Tikellis, Christos, Kantharidis, Phillip, Burns, Wendy C., Cooper, Mark E. and Forbes, Josephine M. (2004). The role of advanced glycation in reduced organic cation transport associated with experimental diabetes. Journal of Pharmacology and Experimental Therapeutics, 311 (2), 456-466. doi: 10.1124/jpet.104.070672

The role of advanced glycation in reduced organic cation transport associated with experimental diabetes

2004

Conference Publication

Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse

Jandeleit-Dahm, KAM, Lassila, M, Seah, KK, Allen, TJ, Thallas, V, Thomas, MC, Candido, R, Burns, WC, Forbes, JM, Calkin, AC and Cooper, ME (2004). Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse. 40th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Munich Germany, Sep 05-09, 2004. SPRINGER.

Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse

2004

Journal Article

Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy

Lee, Fiona T. H., Cao, Zemin, Long, David M., Panagiotopoulos, Sianna, Jerums, George, Cooper, Mark E. and Forbes, Josephine M. (2004). Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. Journal of the American Society of Nephrology, 15 (8), 2139-2151. doi: 10.1097/01.ASN.0000135055.61833.A8

Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy

2004

Journal Article

Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: role of advanced glycation end products

Lassila, Markus, Seah, Kwee K., Allen, Terri J., Thallas, Vicki, Thomas, Merlin C., Candido, Riccardo, Burns, Wendy C., Forbes, Josephine M., Calkin, Anna C., Cooper, Mark E. and Jandeleit-Dahm, Karin A. M. (2004). Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: role of advanced glycation end products. Journal of the American Society of Nephrology, 15 (8), 2125-2138. doi: 10.1097/01.ASN.0000133025.23732.46

Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: role of advanced glycation end products

2004

Journal Article

Advanced glycation end product-interventions reduce diabetes-accelerated atherosclerosis

Forbes, Josephine M., Yee, Louis Teo Loon, Thallas, Vicki, Lassila, Markus, Candido, Riccardo, Jandeleit-Dahm, Karin A., Thomas, Merlin C., Burns, Wendy C., Deemer, Elizabeth K., Thorpe, Susan M., Cooper, Mark E. and Allen, Terri J. (2004). Advanced glycation end product-interventions reduce diabetes-accelerated atherosclerosis. Diabetes, 53 (7), 1813-1823. doi: 10.2337/diabetes.53.7.1813

Advanced glycation end product-interventions reduce diabetes-accelerated atherosclerosis

2004

Journal Article

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats

Wigg, SJ, Tare, M, Forbes, J, Cooper, ME, Thomas, MC, Coleman, HA, Parkington, HC and O'Brien, RC (2004). Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia, 47 (6), 1038-1046. doi: 10.1007/s00125-004-1411-x

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats

2004

Journal Article

Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy

Forbes, Josephine M., Thallas-Bonke, Vicki, Cooper, Mark E. and Thomas, Merlin C. (2004). Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy. Current Pharmaceutical Design, 10 (27), 3361-3372. doi: 10.2174/1381612043383151

Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy

2004

Journal Article

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat

Davis, B. J., Forbes, J. M., Thomas, M. C., Jerums, G., Burns, W. C., Kawachi, H., Allen, T. J. and Cooper, M. E. (2004). Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia, 47 (1), 89-97. doi: 10.1007/s00125-003-1256-8

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat

2004

Journal Article

Identification of angiotensin converting enzyme 2 in the rodent retina

Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W., Thomas, M. C., Lew, R. A., Yarski, M., Smith, A. I. and Cooper, M. E. (2004). Identification of angiotensin converting enzyme 2 in the rodent retina. Current Eye Research, 29 (6), 419-427. doi: 10.1080/02713680490517944

Identification of angiotensin converting enzyme 2 in the rodent retina

2003

Journal Article

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors

Rizkalla, Bizhoy, Forbes, Josephine M., Cooper, Mark E. and Cao, Zemin (2003). Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. Journal of the American Society of Nephrology, 14 (12), 3061-3071. doi: 10.1097/01.ASN.0000099374.58607.C9

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors

2003

Journal Article

Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2

Osicka, Tanya M., Russo, Leileata M., Qiu, Mei-Lan, Brammar, Gail C., Thallas, Vicki, Forbes, Josephine M., Comper, Wayne D. and Jerums, George (2003). Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2. Journal of Hypertension, 21 (12), 2399-2407. doi: 10.1097/00004872-200312000-00029

Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2

2003

Conference Publication

Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.

Boner, G, Thallas, V, Cooper, ME, Rizkalla, B, Qui, ML and Forbes, JM (2003). Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.. 36th Annual Meeting of the American-Society-of-Nephrology, San Diego California, Nov 12-17, 2003. LIPPINCOTT WILLIAMS & WILKINS.

Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.

2003

Journal Article

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease

Jerums, George, Panagiotopoulos, Sianna, Forbes, Josephine, Osicka, Tanya and Cooper, Mark (2003). Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Archives of Biochemistry And Biophysics, 419 (1), 55-62. doi: 10.1016/j.abb.2003.08.017

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease

2003

Conference Publication

Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711

Allen, TJ, Forbes, JM, Yee, LT, Thallas, V, Thomas, MC, Candido, R, Jandeleit-Dahm, KA and Cooper, ME (2003). Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711. 76th Annual Scientific Session of the American-Heart-Association, Orlando Florida, Nov 07-12, 2003. LIPPINCOTT WILLIAMS & WILKINS.

Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711